TGA Approval

KANJINTI trastuzumab 60 mg powder for injection vial (296882)

ARTG ID

296882

ARTG Name

KANJINTI trastuzumab 60 mg powder for injection vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

May 16, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/283d8a5170cda3dcc9f07fd76253a052.pdf

Ingredient Name

Trastuzumab

Empowering clinical research with data-driven insights and AI-powered tools.

KANJINTI trastuzumab 60 mg powder for injection vial (296882) - TGA 批准文号 | MedPath